Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dominic Schinagl"'
Autor:
Edith Dieleman, Lisa van der Woude, Rob van Os, Liselotte van Bockel, Ida Coremans, Corine van Es, Katrien De Jaeger, Hans Peter Knol, Willemijn Kolff, Frederike Koppe, Jacqueline Pomp, Bart Reymen, Dominic Schinagl, Femke Spoelstra, Caroline Tissing-Tan, Noelle van der Voort van Zyp, Antoinet van der Wel, Robin Wijsman, Michel Dielwart, Erwin Wiegman, Ronald Damhuis, Jose Belderbos
Publikováno v:
Clinical Lung Cancer, 24, 2, pp. 130-136
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
In this national lung cancer audit of inoperable NSCLC patients, acute toxicity and 3-month mortality of curative chemoradiation was analyzed. Another important question was whether concurrent chemoradiation for elderly stage III NSCLC patients is sa
Autor:
Harry, Bartelink, Philippe, Maingon, Philip, Poortmans, Caroline, Weltens, Alain, Fourquet, Jos, Jager, Dominic, Schinagl, Bing, Oei, Carla, Rodenhuis, Jean-Claude, Horiot, Henk, Struikmans, Erik, Van Limbergen, Youlia, Kirova, Paula, Elkhuizen, Rudolf, Bongartz, Raymond, Miralbell, David, Morgan, Jean-Bernard, Dubois, Vincent, Remouchamps, René-Olivier, Mirimanoff, Sandra, Collette, Laurence, Collette, F, Kovner
Publikováno v:
Lancet Oncology, 16, 1, pp. 47-56
Lancet Oncology, 16, 47-56
Lancet oncology, 16(1), 47-56. Elsevier Science
LANCET ONCOLOGY, 16(1), 47. Lancet Publishing Group
The Lancet Oncology, Vol. 16, No 1 (2015) pp. 47-56
Lancet Oncology, 16, 47-56
Lancet oncology, 16(1), 47-56. Elsevier Science
LANCET ONCOLOGY, 16(1), 47. Lancet Publishing Group
The Lancet Oncology, Vol. 16, No 1 (2015) pp. 47-56
Item does not contain fulltext BACKGROUND: Since the introduction of breast-conserving treatment, various radiation doses after lumpectomy have been used. In a phase 3 randomised controlled trial, we investigated the effect of a radiation boost of 16